Is There Any Additional Benefit of Contrast-Enhanced CT as Part of Routine PET/CT Protocols for the Differentiation of Suspicious Incidental Gastrointestinal 2-Deoxy--FDG Uptake? |
Brendle, Cornelia Bettina
(Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tuebingen)
Aschoff, Philip (Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tuebingen) Kratt, Thomas (Department of Surgery, University Hospital Tuebingen) Schraml, Christina (Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tuebingen) Reimold, Matthias (Department of Radiology, Nuclear Medicine, University Hospital Tuebingen) Claussen, Claus Detlef (Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tuebingen) Pfannenberg, Christina Anna (Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tuebingen) |
1 | van Kouwen MC, Nagengast FM, Jansen JB, Oyen WJ, Drenth JP. 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol 2005;23:3713-3717 DOI ScienceOn |
2 | Weston BR, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer 2010;116:1454-1461 DOI ScienceOn |
3 | Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose wholebody PET: correlation with histopathologic and CT findings. Radiology 1998;206:755-760 DOI |
4 | Elstrom RL, Leonard JP, Coleman M, Brown RK. Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol 2008;19:1770-1773 DOI ScienceOn |
5 | Pfannenberg AC, Aschoff P, Brechtel K, Müller M, Klein M, Bares R, et al. Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging. Br J Radiol 2007;80:437-445 DOI ScienceOn |
6 | Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 2005;46:758-762 |
7 | Kamel EM, Thumshirn M, Truninger K, Schiesser M, Fried M, Padberg B, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med 2004;45:1804-1810 |
8 | Gutman F, Alberini JL, Wartski M, Vilain D, Le Stanc E, Sarandi F, et al. Incidental colonic focal lesions detected by FDG PET/ CT. AJR Am J Roentgenol 2005;185:495-500 DOI ScienceOn |
9 | Delbeke D. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma. J Nucl Med 1999;40:591-603 |
10 | Engel H, Steinert H, Buck A, Berthold T, Huch Böni RA, von Schulthess GK. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37:441-446 |
11 | Abouzied MM, Crawford ES, Nabi HA. 18F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol 2005;33:145-155; quiz 162-163 |
12 | Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 2002;224:783-787 DOI ScienceOn |
13 | Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005;46:752-757 |
14 | Drenth JP, Nagengast FM, Oyen WJ. Evaluation of (pre-) malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med 2001;28:1766-1769 DOI ScienceOn |
15 | Kei PL, Vikram R, Yeung HW, Stroehlein JR, Macapinlac HA. Incidental finding of focal FDG uptake in the bowel during PET/CT: CT features and correlation with histopathologic results. AJR Am J Roentgenol 2010;194:W401-W406 DOI ScienceOn |
16 | Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel hot spots at PET-CT. Radiographics 2007;27:145-159 DOI ScienceOn |
17 | Yasuda S, Fujii H, Nakahara T, Nishiumi N, Takahashi W, Ide M, et al. 18F-FDG PET detection of colonic adenomas. J Nucl Med 2001;42:989-992 |
18 | Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409-1415 DOI ScienceOn |